Annual Total Assets
$222.51 M
-$28.45 M-11.33%
31 December 2023
Summary:
Heron Therapeutics annual total assets is currently $222.51 million, with the most recent change of -$28.45 million (-11.33%) on 31 December 2023. During the last 3 years, it has fallen by -$131.05 million (-37.07%). HRTX annual total assets is now -56.61% below its all-time high of $512.78 million, reached on 31 December 2019.HRTX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$220.78 M
+$2.64 M+1.21%
30 September 2024
Summary:
Heron Therapeutics quarterly total assets is currently $220.78 million, with the most recent change of +$2.64 million (+1.21%) on 30 September 2024. Over the past year, it has dropped by -$8.42 million (-3.67%). HRTX quarterly total assets is now -56.95% below its all-time high of $512.78 million, reached on 31 December 2019.HRTX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.3% | -3.7% |
| 3 y3 years | -37.1% | -37.4% |
| 5 y5 years | -51.9% | -43.8% |
HRTX Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.1% | at low | -37.4% | +9.7% |
| 5 y | 5 years | -56.6% | at low | -57.0% | +9.7% |
| alltime | all time | -56.6% | +7543.6% | -57.0% | >+9999.0% |
Heron Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $220.78 M(+1.2%) |
| June 2024 | - | $218.14 M(+0.1%) |
| Mar 2024 | - | $217.89 M(-2.1%) |
| Dec 2023 | $222.51 M(-11.3%) | $222.51 M(-2.9%) |
| Sept 2023 | - | $229.20 M(+13.9%) |
| June 2023 | - | $201.22 M(-8.9%) |
| Mar 2023 | - | $220.88 M(-12.0%) |
| Dec 2022 | $250.95 M(-17.9%) | $250.95 M(-7.7%) |
| Sept 2022 | - | $271.95 M(+11.5%) |
| June 2022 | - | $243.97 M(-10.9%) |
| Mar 2022 | - | $273.72 M(-10.5%) |
| Dec 2021 | $305.71 M(-13.5%) | $305.71 M(-13.2%) |
| Sept 2021 | - | $352.39 M(-12.8%) |
| June 2021 | - | $404.25 M(+30.0%) |
| Mar 2021 | - | $310.93 M(-12.1%) |
| Dec 2020 | $353.56 M(-31.1%) | $353.56 M(-9.3%) |
| Sept 2020 | - | $390.02 M(-9.9%) |
| June 2020 | - | $432.72 M(-9.7%) |
| Mar 2020 | - | $478.94 M(-6.6%) |
| Dec 2019 | $512.78 M(+10.9%) | $512.78 M(+30.5%) |
| Sept 2019 | - | $392.96 M(-4.5%) |
| June 2019 | - | $411.67 M(-5.5%) |
| Mar 2019 | - | $435.79 M(-5.7%) |
| Dec 2018 | $462.18 M(+97.3%) | $462.18 M(-1.9%) |
| Sept 2018 | - | $470.90 M(-7.8%) |
| June 2018 | - | $510.56 M(+178.4%) |
| Mar 2018 | - | $183.38 M(-21.7%) |
| Dec 2017 | $234.31 M(+247.2%) | $234.31 M(+98.2%) |
| Sept 2017 | - | $118.20 M(-17.0%) |
| June 2017 | - | $142.37 M(-24.9%) |
| Mar 2017 | - | $189.56 M(+180.9%) |
| Dec 2016 | $67.48 M(-51.0%) | $67.48 M(-31.7%) |
| Sept 2016 | - | $98.81 M(+15.3%) |
| June 2016 | - | $85.73 M(-23.3%) |
| Mar 2016 | - | $111.85 M(-18.9%) |
| Dec 2015 | $137.84 M(+79.8%) | $137.84 M(-12.8%) |
| Sept 2015 | - | $158.15 M(-10.4%) |
| June 2015 | - | $176.46 M(+195.9%) |
| Mar 2015 | - | $59.63 M(-22.2%) |
| Dec 2014 | $76.68 M(+1.0%) | $76.68 M(-16.9%) |
| Sept 2014 | - | $92.28 M(-15.1%) |
| June 2014 | - | $108.64 M(+73.0%) |
| Mar 2014 | - | $62.79 M(-17.3%) |
| Dec 2013 | $75.94 M(+35.7%) | $75.94 M(+188.0%) |
| Sept 2013 | - | $26.37 M(-30.8%) |
| June 2013 | - | $38.09 M(-22.2%) |
| Mar 2013 | - | $48.98 M(-12.5%) |
| Dec 2012 | $55.97 M(+187.8%) | $55.97 M(-9.4%) |
| Sept 2012 | - | $61.76 M(+334.0%) |
| June 2012 | - | $14.23 M(-5.1%) |
| Mar 2012 | - | $14.99 M(-22.9%) |
| Dec 2011 | $19.45 M(+568.0%) | $19.45 M(-10.8%) |
| Sept 2011 | - | $21.80 M(-1.5%) |
| June 2011 | - | $22.12 M(+1086.1%) |
| Mar 2011 | - | $1.86 M(-35.9%) |
| Dec 2010 | $2.91 M(-67.5%) | $2.91 M(-28.8%) |
| Sept 2010 | - | $4.09 M(-40.3%) |
| June 2010 | - | $6.85 M(-22.2%) |
| Mar 2010 | - | $8.80 M(-1.6%) |
| Dec 2009 | $8.95 M(-24.1%) | $8.95 M(+194.7%) |
| Sept 2009 | - | $3.04 M(-36.6%) |
| June 2009 | - | $4.79 M(-44.5%) |
| Mar 2009 | - | $8.64 M(-26.8%) |
| Dec 2008 | $11.80 M(-68.1%) | $11.80 M(-34.7%) |
| Sept 2008 | - | $18.06 M(-22.9%) |
| June 2008 | - | $23.43 M(-21.0%) |
| Mar 2008 | - | $29.67 M(-19.7%) |
| Dec 2007 | $36.95 M(+114.2%) | $36.95 M(-11.3%) |
| Sept 2007 | - | $41.64 M(-10.9%) |
| June 2007 | - | $46.71 M(+326.1%) |
| Mar 2007 | - | $10.96 M(-36.5%) |
| Dec 2006 | $17.25 M | $17.25 M(-13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $19.95 M(-15.1%) |
| June 2006 | - | $23.50 M(-15.6%) |
| Mar 2006 | - | $27.85 M(+210.5%) |
| Dec 2005 | $8.97 M(-47.3%) | $8.97 M(-20.1%) |
| Sept 2005 | - | $11.23 M(-12.7%) |
| June 2005 | - | $12.87 M(-13.6%) |
| Mar 2005 | - | $14.90 M(-12.4%) |
| Dec 2004 | $17.01 M(+29.3%) | $17.01 M(-8.4%) |
| Sept 2004 | - | $18.58 M(-7.4%) |
| June 2004 | - | $20.05 M(+78.0%) |
| Mar 2004 | - | $11.27 M(-14.4%) |
| Dec 2003 | $13.15 M(-26.0%) | $13.15 M(-10.4%) |
| Sept 2003 | - | $14.68 M(-7.7%) |
| June 2003 | - | $15.91 M(-12.0%) |
| Mar 2003 | - | $18.08 M(+1.7%) |
| Dec 2002 | $17.78 M(-24.4%) | $17.78 M(-6.0%) |
| Sept 2002 | - | $18.91 M(-7.6%) |
| June 2002 | - | $20.46 M(-5.7%) |
| Mar 2002 | - | $21.69 M(-7.7%) |
| Dec 2001 | $23.51 M(-12.9%) | $23.51 M(-5.1%) |
| Sept 2001 | - | $24.77 M(+3.6%) |
| June 2001 | - | $23.92 M(-4.6%) |
| Mar 2001 | - | $25.07 M(-7.1%) |
| Dec 2000 | $27.00 M(+39.9%) | $27.00 M(-6.9%) |
| Sept 2000 | - | $29.01 M(+55.6%) |
| June 2000 | - | $18.65 M(-17.1%) |
| Mar 2000 | - | $22.49 M(+16.5%) |
| Dec 1999 | $19.30 M(-16.5%) | $19.30 M(-18.6%) |
| Sept 1999 | - | $23.70 M(0.0%) |
| June 1999 | - | $23.70 M(-4.8%) |
| Mar 1999 | - | $24.90 M(+7.8%) |
| Dec 1998 | $23.10 M(-4.5%) | $23.10 M(-2.5%) |
| Sept 1998 | - | $23.70 M(-2.9%) |
| June 1998 | - | $24.40 M(-0.8%) |
| Mar 1998 | - | $24.60 M(+1.7%) |
| Dec 1997 | $24.20 M(+31.5%) | $24.20 M(+8.0%) |
| Sept 1997 | - | $22.40 M(+6.7%) |
| June 1997 | - | $21.00 M(+7.1%) |
| Mar 1997 | - | $19.60 M(+6.5%) |
| Dec 1996 | $18.40 M(-20.3%) | $18.40 M(-21.7%) |
| Sept 1996 | - | $23.50 M(-7.5%) |
| June 1996 | - | $25.40 M(+3.3%) |
| Mar 1996 | - | $24.60 M(+6.5%) |
| Dec 1995 | $23.10 M(-1.7%) | $23.10 M(-13.8%) |
| Sept 1995 | - | $26.80 M(+3.9%) |
| June 1995 | - | $25.80 M(-7.5%) |
| Mar 1995 | - | $27.90 M(+18.7%) |
| Dec 1994 | $23.50 M(-3.7%) | $23.50 M(-8.9%) |
| Sept 1994 | - | $25.80 M(-14.3%) |
| June 1994 | - | $30.10 M(+7.9%) |
| Mar 1994 | - | $27.90 M(+14.3%) |
| Dec 1993 | $24.40 M(-13.8%) | $24.40 M(-5.4%) |
| Sept 1993 | - | $25.80 M(-18.6%) |
| June 1993 | - | $31.70 M(+20.1%) |
| Mar 1993 | - | $26.40 M(-6.7%) |
| Dec 1992 | $28.30 M(+194.8%) | $28.30 M(-5.4%) |
| Sept 1992 | - | $29.90 M(+22.0%) |
| June 1992 | - | $24.50 M(+19.5%) |
| Mar 1992 | - | $20.50 M(+113.5%) |
| Dec 1991 | $9.60 M(-17.2%) | $9.60 M(+5.5%) |
| Sept 1991 | - | $9.10 M(-9.0%) |
| June 1991 | - | $10.00 M(-2.0%) |
| Mar 1991 | - | $10.20 M(-12.1%) |
| Dec 1990 | $11.60 M(-12.1%) | $11.60 M(+8.4%) |
| Sept 1990 | - | $10.70 M(-10.1%) |
| June 1990 | - | $11.90 M(-3.3%) |
| Mar 1990 | - | $12.30 M(-6.8%) |
| Dec 1989 | $13.20 M(-21.4%) | $13.20 M(-8.3%) |
| Sept 1989 | - | $14.40 M(-6.5%) |
| June 1989 | - | $15.40 M(-8.3%) |
| Dec 1988 | $16.80 M(-20.0%) | $16.80 M(-20.0%) |
| Dec 1987 | $21.00 M | $21.00 M |
FAQ
- What is Heron Therapeutics annual total assets?
- What is the all time high annual total assets for Heron Therapeutics?
- What is Heron Therapeutics annual total assets year-on-year change?
- What is Heron Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Heron Therapeutics?
- What is Heron Therapeutics quarterly total assets year-on-year change?
What is Heron Therapeutics annual total assets?
The current annual total assets of HRTX is $222.51 M
What is the all time high annual total assets for Heron Therapeutics?
Heron Therapeutics all-time high annual total assets is $512.78 M
What is Heron Therapeutics annual total assets year-on-year change?
Over the past year, HRTX annual total assets has changed by -$28.45 M (-11.33%)
What is Heron Therapeutics quarterly total assets?
The current quarterly total assets of HRTX is $220.78 M
What is the all time high quarterly total assets for Heron Therapeutics?
Heron Therapeutics all-time high quarterly total assets is $512.78 M
What is Heron Therapeutics quarterly total assets year-on-year change?
Over the past year, HRTX quarterly total assets has changed by -$8.42 M (-3.67%)